Filing Details
- Accession Number:
- 0001104659-20-050349
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-23 16:31:28
- Reporting Period:
- 2020-04-21
- Accepted Time:
- 2020-04-23 16:31:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1609550 | Inspire Medical Systems Inc. | INSP | Surgical & Medical Instruments & Apparatus (3841) | 261377674 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1737203 | Steven Jandrich | C/O Inspire Medical Systems, Inc. 5500 Wayzata Blvd., Suite 1600 Golden Valley MN 55416 | Chief Comp Off & Vp, Human Res | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-21 | 2,000 | $0.94 | 3,805 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-21 | 2,000 | $72.68 | 1,805 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-04-21 | 2,000 | $0.00 | 2,000 | $0.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 28,075 | 2027-09-25 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 350 | Indirect | By son |
| Common Stock | 350 | Indirect | By daughter |
Footnotes
- Includes 455 additional shares acquired under the Company's 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on December 18, 2019.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The option is fully vested and exercisable.
- This option grant was previously reported as having an expiration date of September 24, 2027, which has been revised herein.
Billionaire Hedge Funds
